Treatment options in XXXX .

@entity1 @entity410 @entity302
Recent evidence suggests that various @entity302 respond differently to antiepileptic drugs. It follows that a more precise diagnosis, together with a better understanding of AED mechanisms of action, enables them to be used more specifically, and therefore more effectively. @entity1 characteristics including age of onset, @entity410 frequency, EEG data and the findings of imaging studies, provide diagnostic pointers which enable the physician to reach a syndrome diagnosis and to choose the most appropriate AED for the individual @entity1 . Home videotapes of paroxysmal events are becoming increasingly available and are often of great assistance. Parents should be encouraged to record their @entity1 's attacks. Careful history-taking and correct interpretation of clinical data remain the cornerstones of accurate diagnosis and successful treatment. However, the specificity of antiepileptic drugs is relatively limited and often pharmacotherapy should start using an agent with a broad spectrum of activity appropriate for the primary @entity410 type. It is in fact common that several antiepileptic agents have similar or identical effectiveness for one particular form of @entity302 . Therefore, the eventual side effects and the greater or lesser difficulties in handling the drug play an essential role in the choice of a therapeutic agent. Polypharmacy should be avoided and surgery should be considered early for selected @entity1 , particularly @entity1 , who fail to respond to an appropriate drug trial. Correct diagnosis and the first drug(s) used may have a crucial impact on the evolution of given @entity302 . One major emphasis in the management of @entity302 is on information that should be complete, adapted to the level of understanding, and objective, although given in a positive manner. The understanding and cooperation of @entity1 and their families is clearly decisive for the success of therapy, and this requires a confident relationship between the physician and the @entity1 . Current knowledge, on antiepileptic drugs options in @entity302 , is discussed.
